Results
|
1.
|
TKIs beyond immunotherapy predict improved survival in advanced HCC. MedStar authors:
Year: 2023
Citation: - Journal of Cancer Research & Clinical Oncology. 149(6):2559-2574, 2023 Jun.
Institution: - MedStar Georgetown University Hospital/MedStar Washington Hospital Center
Department: - Internal Medicine Residency
Medline publication type:
All authors: - Armstrong S, Geng X, Hartley ML, He AR, Jha RC, Kulasekaran M, Prins P, Roy T, Shaukat F, Singh B, Wang H
|
|
2.
|
|
|
3.
|
Vemurafenib-induced DRESS. MedStar authors:
- Jang, Sekwon
- Nasabzadeh, Teresa
- Pichard, Dominique C
- Wenk, Kurt S
Year: 2013
Citation: - JAMA Dermatology. 149(10):1242-3, 2013 Oct.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Case Reports
- Journal Article
All authors: - Jang S, Nasabzadeh T, Pichard DC, Venna SS, Wenk KS
|
|
4.
|
|
|
5.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|